Cancer Diagnostics – News and Features
News
“Pan-Cancer” Marker Detected in Ultrasensitive Blood Test
Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.
News
ctDNA Shows Promise as a Prognostic Biomarker for Advanced Melanoma
Measuring circulating tumor DNA may lead to alternative treatment options and better outcomes for patients with advanced BRAF-negative melanoma, report investigates in The Journal of Molecular Diagnostics.
News
Liquid Biopsy Could Guide Treatment Decisions for Oligometastatic Lung Cancer
A new study could help doctors decide the best treatment strategy for patients with lung cancer that has spread beyond the original tumor but has not spread all over the body.
News
New Genetic Markers To Detect Lynch Syndrome-Associated Colorectal Cancer Identified
Lynch syndrome is an inherited genetic condition that significantly increases the risk of multiple cancers. Researchers have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy.
News
Early-Stage Breast Cancers Detected From Breastmilk
Researchers have shown for the first time that breast milk from breast cancer patients contains tumor DNA, known as circulating tumor DNA (ctDNA). This can be detected through liquid biopsy in breast milk.
News
Mammogram-Reading AI Performs Comparably to Humans
Using a standardized assessment, researchers in the UK compared the performance of a commercially available AI algorithm with human readers of screening mammograms.
News
New RNA Liquid Biopsy Platform Improves Cancer Detection
A new liquid biopsy platform has been developed that uses RNA "dark matter" to diagnose cancer types including pancreatic, lung and esophageal, in the early stages.
Article
Trends and Advancements in Proteomics
Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.
News
Precision Cancer Drug Development Approach Could Be $1 Billion Cheaper
Research and Development costs for targeted oncology drugs are markedly lower if guided by a companion diagnostic strategy, but current biopharmaceutical business models suggest these savings will not be reflected in more affordable pricing.
Article
Oncology Researchers: Are You Getting the Most From Your Digital PCR Data?
This article discusses what good dPCR data looks like, how substandard equipment can detract from data quality and what oncology researchers can do to get high-quality dPCR data that will provide accurate and efficient insight into tumor load.
Advertisement